Clinical Trials on Human Papillomavirus Infection in Canada

Total 3281 results

Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada (COPE)

Covid19 | Pregnancy | Corona Virus Infection | SARS-CoV-2 | Infectious Disease Transmission, Vertical

Canada
Vancouver Infectious Diseases Centre

Recruiting

Eliminating HCV Infection Among PWUD

Hepatitis C, Chronic | Drug Use

Canada
Canadian Immunization Research Network
CHU de Quebec-Universite Laval; McGill University Health Centre/Research Institute... and other collaborators

Completed

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

Influenza

Canada
University of British Columbia
British Columbia Cancer Agency

Unknown

TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment

Latent Tuberculosis Infection

Canada
Janssen Infectious Diseases BVBA

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Hepatitis C Virus Infection

United States, Canada
Ottawa Hospital Research Institute
Pfizer

Completed

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc (RIFAMARA)

HIV Infection | HIV-1 Infection | Mycobacterium Avium Complex (MAC)

Canada
David Scheifele
Canadian Institutes of Health Research (CIHR)

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

Influenza | H1N1 2009 Influenza

Canada
Ottawa Hospital Research Institute

Recruiting

Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

Hepatitis B, Chronic

Canada
Sunnybrook Health Sciences Centre

Enrolling by invitation

Use of Preoperative and Postoperative Antimicrobial Treatment

Surgical Site Infection | Antibiotic Side Effect | Ear Infection Bacterial

Canada
University Health Network, Toronto

Recruiting

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Hepatitis B, Chronic

Canada
ViiV Healthcare
GlaxoSmithKline

Completed

A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Infection, Human Immunodeficiency Virus

United States, France, Spain, Canada, Italy
Janssen Infectious Diseases BVBA

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Hepatitis C Virus Infection

United States, Canada
Cargill
INQUIS Clinical Research Ltd.

Completed

The Impact of Steviol Glycosides on Human Gut Microflora Profile and Function

Healthy | Human Gut Microflora

Canada
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults (SAILING)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
ViiV Healthcare
GlaxoSmithKline

Completed

Dolutegravir Expanded Access Study (DEAP)

HIV Infections | Infection, Human Immunodeficiency Virus

France, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
Mark Loeb

Not yet recruiting

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Coronavirus Infection | SARS-CoV2 Infection

Canada
Gilead Sciences

Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Hepatitis C Virus Infection

Germany, United States, Australia, United Kingdom, Canada, France, New Zealand
Marina Klein
Schering-Plough; Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Trial of Citalopram for the Prevention of Depression (PICCO)

Depression | HIV Infections | Hepatitis C

Canada
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection (ASTRAL-1)

Hepatitis C Virus Infection

United States, France, Canada, Germany, Puerto Rico, United Kingdom, Belgium, Italy, China
University of Alberta

Completed

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Cytomegalovirus Infection

Canada
NuBiyota

Completed

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Clostridium Difficile Infection

Canada
University of Calgary
Janssen Inc.

Completed

Infliximab IBD Influenza Vaccine Study

Inflammatory Bowel Disease

Canada
OPKO Health, Inc.

Completed

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Hepatitis, Viral, Human | Chronic Hepatitis C

Canada
British Columbia Centre for Disease Control

Completed

Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity (TITRE)

Influenza

Canada
Vancouver Island Health Authority

Recruiting

Ceftriaxone as Home IV for Staph Infections

Abscess | Staphylococcal Infections | Diabetic Foot Infection | Osteomyelitis | Vertebral Osteomyelitis | CNS Infection | Septic Arthritis | Coagulase Negative Staphylococcal Infection

Canada
Population Health Research Institute

Active, not recruiting

Prevention of Infections in Cardiac Surgery (PICS) Prevena Study (PICS-Prevena)

Surgical Site Infections

Canada
Canadian Immunodeficiency Research Collaborative

Completed

Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression

Human Immunodeficiency Virus

Canada
David Scheifele
Canadian Institutes of Health Research (CIHR); PHAC/CIHR Influenza Research...

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

H1N1/2009 Influenza

Canada
GlaxoSmithKline

Completed

Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015

Influenza, Human

Panama
CHU de Quebec-Universite Laval

Completed

DECISION+, a Training Program to Improve Optimal Drug Prescription (Decision+)

Acute Respiratory Infections

Canada
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Influenza

United States, Canada
Louis Bherer

Completed

Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue (COVID-Rehab)

COVID-19 Respiratory Infection

Canada
Dalhousie University
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR); IWK Health Centre

Completed

Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children

Seasonal Influenza

Canada
Lawson Health Research Institute
London Health Sciences Centre

Completed

London's Exogenous Surfactant Study for COVID19 (LESSCOVID)

COVID-19 | ARDS, Human

Canada
University Health Network, Toronto

Terminated

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Chronic Hepatitis C - Genotype 3

Canada
GlaxoSmithKline

Completed

Analysis of Trends Over Time of Hepatitis Related Incidence in Panama

Hepatitis

Panama
Unity Health Toronto
Gilead Sciences; Ryerson University; Maple Leaf Research; AIDS Committee of Toronto and other collaborators

Completed

PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5 (PREP-5)

HIV | Human Immunodeficiency Virus

Canada
Vancouver Island Health Authority

Unknown

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection

Canada
University of Calgary
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR)

Completed

A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

Vaccine Reaction | Hepatitis B | Non-Alcoholic Fatty Liver Disease

Canada
Gilead Sciences

Completed

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Chronic Genotype 1a or 1b HCV Infection

United States, Canada, Puerto Rico
Sona Nanotech Inc

Terminated

Performance Study of SONA Saliva C-19 Rapid Test

Covid19 | Corona Virus Infection | Sars-CoV-2 Infection

Canada
trueNorth Medical Centres
Gilead Sciences

Recruiting

Re-link HCV in Substance-Use Telemedicine Program

Hepatitis C

Canada
Laval University
Canadian Institutes of Health Research (CIHR)

Completed

Physical and Cognitive Impairments in People Suffering From Long COVID

COVID-19 | Quality of Life | Cognitive Impairment | Cognitive Dysfunction | Corona Virus Infection | Physical Disability | SARS-CoV-2 Infection | Impairment | Symptoms and Signs

Canada
GlaxoSmithKline

Terminated

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

Haemophilus Influenzae | Streptococcus Pneumoniae

Canada
University Health Network, Toronto
Gilead Sciences

Completed

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Hepatitis C, Chronic | Cirrhosis, Decompensated

Canada
University of Calgary

Completed

Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy

Autoimmune Rheumatologic Disease

Canada
University of British Columbia
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR)

Completed

Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011 (PCIRNRT06)

Influenza

Canada
GlaxoSmithKline

Completed

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

Hepatitis B Vaccine

Belgium, Canada
Janssen Research & Development, LLC

Completed

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection (ACCORDION-1)

Hepatitis C Virus

United States, Canada
Gilead Sciences
Merck Sharp & Dohme LLC

Completed

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Hepatitis C

Japan

Clinical Trials on Human Papillomavirus Infection in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations